PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
3321540-3	1987	Oral terbutaline improved morning peak flow (259 v 213 l min-1) and decreased nocturnal inhaler usage (1.3 v 1.9) with no alteration in sleep quality as assessed electroencephalographically.	Terbutaline	5-16	CD59 molecule (CD59 blood group)	Homo sapiens	57-62	
6751838-3	1981	Four increasing doses of terbutaline (0.036-1.23 micrograms kg-1 min-1) were thereafter administered by intravenous infusion, starting 120 min after the tablet intake.	Terbutaline	25-36	CD59 molecule (CD59 blood group)	Homo sapiens	65-70	
17177114-8	2007	For the Bricanyl Turbohaler, increasing FIR from 120 to 600 l min(-1) s(-1) for a constant peak flow rate (PFR) of 60 l min(-1) increased the mean Terbutaline FPF from 18.2% to 45.5%.	Terbutaline	147-158	CD59 molecule (CD59 blood group)	Homo sapiens	62-68	
17177114-8	2007	For the Bricanyl Turbohaler, increasing FIR from 120 to 600 l min(-1) s(-1) for a constant peak flow rate (PFR) of 60 l min(-1) increased the mean Terbutaline FPF from 18.2% to 45.5%.	Terbutaline	147-158	CD59 molecule (CD59 blood group)	Homo sapiens	120-126	
10955752-12	2000	Evening peak flows were significantly higher during terbutaline treatment [mean increase 23.1 l min(-1) (95% CI = 18.8, 27.4)].	Terbutaline	52-63	CD59 molecule (CD59 blood group)	Homo sapiens	96-102	
12412676-7	2002	Statistically greater increases in cardiac frequency (2.6 beats x min(-1), p=0.03) were found on terbutaline.	Terbutaline	97-108	CD59 molecule (CD59 blood group)	Homo sapiens	66-72	
10955752-15	2000	On ceasing terbutaline treatment there was a fall in mean morning peak flow below the baseline on the following morning of 21.6 l min(-1) (P<0.05 compared to placebo).	Terbutaline	11-22	CD59 molecule (CD59 blood group)	Homo sapiens	130-136	
9643620-8	1998	A similar renal clearance of bambuterol was found during oral administration but that of terbutaline decreased (to about 120 ml min(-1)).	Terbutaline	89-100	CD59 molecule (CD59 blood group)	Homo sapiens	128-134	
8112441-6	1993	After treatment with bambuterol, mean morning and evening PEF (SD) were 347 (122) and 365 (121) l.min-1, respectively and 346 (121) and 365 (122) l.min-1, respectively, after treatment with terbutaline.	Terbutaline	190-201	CD59 molecule (CD59 blood group)	Homo sapiens	148-153	
8143834-6	1994	Mean lung deposition of terbutaline sulphate inhaled at 57 l.min-1 was 27.0 +/- 7.7%.	Terbutaline	24-44	CD59 molecule (CD59 blood group)	Homo sapiens	61-66	
1576070-10	1992	Reducing the inspiratory flow to approximately 34 l min-1 produced slightly reduced side effects and lower plasma terbutaline concentrations.	Terbutaline	114-125	CD59 molecule (CD59 blood group)	Homo sapiens	52-57